| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $109K | -70.5% |
| R&D Expense | $5.5M | -38.1% |
| SG&A Expense | $9.7M | +5.2% |
| Operating Income | -$15.1M | +14.9% |
| Income Tax | $2K | +0.0% |
| Net Income | -$14.7M | +15.0% |
| EPS (Basic) | -$1.60 | +19.2% |
| EPS (Diluted) | -$1.60 | +19.2% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.9M | -81.0% |
| Accounts Receivable | $33K | -78.3% |
| Inventory | $297K | — |
| Current Assets | $3.9M | -76.9% |
| Total Assets | $6.3M | -68.7% |
| Current Liabilities | $1.9M | -49.3% |
| Total Liabilities | $2.7M | -44.9% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.7M | -18.1% |
| Capital Expenditures | $42K | -89.4% |
| Investing Cash Flow | $816K | +184.5% |
| Financing Cash Flow | $1.4M | — |
| Free Cash Flow | -$14.7M | -14.8% |
| Stockholders' Equity |
| $3.6M |
| -76.5% |